Welcome to Synthesis Spotlight!

You're joining 2,500+ readers worldwide—from prestigious universities such as Harvard, Cambridge, and ETH Zürich, to pharmaceutical giants, like Vertex, Merck, and Roche.

We're here to do two things:

1. To keep you up-to-date with the latest developments in synthetic organic chemistry.

2. To package this information into an easy to read 15-minute newsletter sent straight to your inbox every Monday morning.

👉 Check your inbox for a welcome email! (don't forget to check spam and promotions too).

—Steve

👋 While you’re here, why not check out some of our previous posts below!